GSTDTAP  > 地球科学
DOI10.1126/science.aat8407
Poly(ADP-ribose) drives pathologic alpha-synuclein neurodegeneration in Parkinson's disease
Kam, Tae-In1,2,3,4; Mao, Xiaobo1,2,3,4; Park, Hyejin1,2,3,4; Chou, Shih-Ching1,2,5; Karuppagounder, Senthilkumar S.1,2,3,4; Umanah, George Essien1,2,3; Yun, Seung Pil1,2,3,4; Brahmachari, Saurav1,2,3,4; Panicker, Nikhil1,2,3,4; Chen, Rong1,2,3,4; Andrabi, Shaida A.1,2,3,14; Qi, Chen1,2,3,6; Poirier, Guy G.7; Pletnikova, Olga8; Troncoso, Juan C.3,8; Bekris, Lynn M.9; Leverenz, James B.10,11; Pantelyat, Alexander3; Ko, Han Seok1,2,3,4; Rosenthal, Liana S.3; Dawson, Ted M.1,2,3,4,5,12; Dawson, Valina L.1,2,3,4,12,13
2018-11-02
发表期刊SCIENCE
ISSN0036-8075
EISSN1095-9203
出版年2018
卷号362期号:6414页码:557-+
文章类型Article
语种英语
国家USA; Peoples R China; Canada
英文摘要

The pathologic accumulation and aggregation of alpha-synuclein (alpha-syn) underlies Parkinson's disease (PD). The molecular mechanisms by which pathologic alpha-syn causes neurodegeneration in PD are not known. Here, we found that pathologic alpha-syn activates poly(adenosine 5'-diphosphate-ribose) (PAR) polymerase-1 (PARP-1), and PAR generation accelerates the formation of pathologic alpha-syn, resulting in cell death via parthanatos. PARP inhibitors or genetic deletion of PARP-1 prevented pathologic alpha-syn toxicity. In a feed-forward loop, PAR converted pathologic alpha-syn to a more toxic strain. PAR levels were increased in the cerebrospinal fluid and brains of patients with PD, suggesting that PARP activation plays a role in PD pathogenesis. Thus, strategies aimed at inhibiting PARP-1 activation could hold promise as a disease-modifying therapy to prevent the loss of dopamine neurons in PD.


领域地球科学 ; 气候变化 ; 资源环境
收录类别SCI-E
WOS记录号WOS:000450460000037
WOS关键词CELL-DEATH ; MECHANISMS ; AGGREGATION ; STRAINS ; PROTEIN
WOS类目Multidisciplinary Sciences
WOS研究方向Science & Technology - Other Topics
引用统计
文献类型期刊论文
条目标识符http://119.78.100.173/C666/handle/2XK7JSWQ/199985
专题地球科学
资源环境科学
气候变化
作者单位1.Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat Program, Baltimore, MD 21205 USA;
2.Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD 21205 USA;
3.Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA;
4.Adrienne Helis Malvin Med Res Fdn, New Orleans, LA 70130 USA;
5.Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA;
6.Shanghai Jiao Tong Univ, Dept Neurol, Xin Hua Hosp, Sch Med, Shanghai 200092, Peoples R China;
7.Univ Laval, Fac Med, Ctr Rech, CHU Quebec Pavillon,CHUL, Quebec City, PQ G1V 4G2, Canada;
8.Johns Hopkins Univ, Sch Med, Dept Pathol Neuropathol, Baltimore, MD 21205 USA;
9.Cleveland Clin, Lerner Res Inst, Genom Med, Cleveland, OH 44195 USA;
10.Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Neurol Inst, Cleveland, OH 44195 USA;
11.Cleveland Clin, Dept Neurol, Cleveland, OH 44195 USA;
12.Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA;
13.Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA;
14.Univ Alabama Birmingham, Sch Med, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA
推荐引用方式
GB/T 7714
Kam, Tae-In,Mao, Xiaobo,Park, Hyejin,et al. Poly(ADP-ribose) drives pathologic alpha-synuclein neurodegeneration in Parkinson's disease[J]. SCIENCE,2018,362(6414):557-+.
APA Kam, Tae-In.,Mao, Xiaobo.,Park, Hyejin.,Chou, Shih-Ching.,Karuppagounder, Senthilkumar S..,...&Dawson, Valina L..(2018).Poly(ADP-ribose) drives pathologic alpha-synuclein neurodegeneration in Parkinson's disease.SCIENCE,362(6414),557-+.
MLA Kam, Tae-In,et al."Poly(ADP-ribose) drives pathologic alpha-synuclein neurodegeneration in Parkinson's disease".SCIENCE 362.6414(2018):557-+.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Kam, Tae-In]的文章
[Mao, Xiaobo]的文章
[Park, Hyejin]的文章
百度学术
百度学术中相似的文章
[Kam, Tae-In]的文章
[Mao, Xiaobo]的文章
[Park, Hyejin]的文章
必应学术
必应学术中相似的文章
[Kam, Tae-In]的文章
[Mao, Xiaobo]的文章
[Park, Hyejin]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。